Peripheral drug-eluting stent for arterial disease treatment, delivering sirolimus to prevent restenosis in peripheral vasculature.
Manufactured by
China
Shanghai Easy-Flow Medical Tech Co., Ltd. (Shanghai, 2021) is a leading innovator and manufacturer in interventional vascular therapy.Our Focus:Lower extremity arterial stenosis intervention therapyThombus managementInterventional treatment of venous diseasesChronic disease managementOur Products:Stent systems, thrombectomy devices, and advanced vascular intervention solutions.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Zhejiang Barty Medical Technology Co.,ltd.
China · 2 relevant products
Lepu Medical (Europe) Inc. Coöperatief U.A
Netherlands · 3 relevant products
GENOSS CO., Ltd.
South Korea · 4 relevant products
Relisys Medical Devices Ltd
India · 4 relevant products
USM Healthcare Medical Devices Factory JSC
Vietnam · 3 relevant products
Vasmed Technologies Ltd FZC
United Arab Emirates · 2 relevant products
Sonosemi Medical Co., Ltd.
China · 3 relevant products
TT MEDICAL, INC.
China · 4 relevant products
Kossel Medtech (Suzhou) Co., Ltd.
China · 2 relevant products
AMT MEDICAL Inc
China · 1 relevant product
50 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →3 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 109 closest product alternatives
Zhejiang Barty Medical Technology Co.,ltd. · China
A drug-eluting stent system designed for peripheral vascular applications. It provides structural support while releasing therapeutic agents to reduce restenosis in peripheral arteries.
Lepu Medical (Europe) Inc. Coöperatief U.A · Netherlands
Bioabsorbable sirolimus-eluting stent system designed for percutaneous coronary intervention (PCI) in coronary artery disease. The stent delivers sirolimus to inhibit neointimal hyperplasia while the polymer scaffold gradually resorbs, restoring vasomotor function. Indicated for patients with de novo coronary lesions requiring revascularization.
GENOSS CO., Ltd. · South Korea
Drug-eluting stent for peripheral vascular interventions. Designed to expand narrowed peripheral vessels and maintain vessel patency.
Relisys Medical Devices Ltd · India
A coronary stent coated with antiproliferative medication to reduce restenosis rates following percutaneous coronary intervention. Provides sustained drug delivery to the vessel wall over extended periods.
USM Healthcare Medical Devices Factory JSC · Vietnam
A coronary stent system designed to deliver therapeutic agents directly to arterial lesions, reducing restenosis rates in percutaneous coronary intervention procedures. Manufactured in Vietnam with proven clinical efficacy and biocompatibility.
Relisys Medical Devices Ltd · India
A drug-eluting coronary stent system designed to treat coronary artery disease by delivering sirolimus to prevent restenosis. The stent is placed via percutaneous coronary intervention to restore blood flow in narrowed arteries.
Vasmed Technologies Ltd FZC · United Arab Emirates
Drug-eluting coronary stent for percutaneous transluminal coronary angioplasty reducing restenosis in atherosclerotic lesions.
Sonosemi Medical Co., Ltd. · China
Advanced stent platform with pharmaceutical coating for coronary applications. Reduces restenosis risk while maintaining vessel patency in patients with coronary artery disease.
TT MEDICAL, INC. · China
Drug-eluting and bare metal stent platforms for coronary artery disease treatment and acute coronary syndrome management.
Kossel Medtech (Suzhou) Co., Ltd. · China
MiStent® is a sirolimus-eluting coronary stent with absorbable polymer coating designed for percutaneous coronary intervention. The cobalt chromium alloy structure provides sustained radial support and fatigue resistance for treating coronary artery stenosis. The drug-eluting mechanism reduces neointimal proliferation while the absorbable polymer eliminates chronic inflammatory response after healing.
AMT MEDICAL Inc · China
Bioresorbable drug-eluting stent system designed for peripheral vascular intervention in patients with stenotic or occluded peripheral arteries. The stent gradually resorbs while delivering therapeutic agents to prevent restenosis, restoring blood flow in lower extremity and other peripheral vascular applications.
Shanjie Medical Technology (Zhengzhou) Co., LTD · China
Drug-eluting stent platforms that combine mechanical support with pharmaceutical delivery mechanisms for vascular applications. The product line includes multiple proprietary formulations and coating technologies.
97 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products